Content Types

Explained 1

View All

Why We Invested in Fervo Energy

By Dr. Rachel Slaybaugh

Essays 3

View All

Why We Invested in Fervo Energy

By Dr. Rachel Slaybaugh

Reinventing Cement for a Zero-Carbon Future

By Zachary Bogue

2021 and Deep Tech: Reasons for Optimism

By Matthew Ocko, Zachary Bogue

DCVC Announcements 27

View All

DCVC Announcements

DCVC 2025 Q4 update

DCVC Announcements

DCVC 2025 Q3 update

DCVC Announcements

DCVC 2025 Q2 update

DCVC Announcements

DCVC 2025 Q1 update

Q&A 12

View All

Automated, localized, fast: why a top apparel leader is getting behind unspun’s fabric tech

Reality Defender democratizes deepfake detection with public API launch

Reality Defender answers FINRA call

Deep tech to defeat deepfakes: Reality Defender is on the case

Snapshot 3

View All

Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells

By Jason Pontin

CH4 Global set to launch world's first commercial scale Asparagopsis production facility

How Noetik uses images to give its AI model a deeper understanding of cancer

Company Profile 8

View All

Company Profile

Why Kanvas built its own production line for microbiome therapeutics

By Jason Pontin

Company Profile

Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy

Company Profile

Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits

By Dr. Emily Park, Dr. Kiersten Stead

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

News 123

View All

Neutralizing the swarm: Fortem cements its position as the go-to for drone defense

By Matthew Ocko

A new pinnacle in fault tolerant quantum computing

By Dr. Prineha Narang

Valar’s AI-derived biomarker is a game-changer for treating pancreatic cancer

By James Hardiman

Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions

By Jason Pontin

Thoughts 31

View All

Quantum’s super position

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

Human identity needs a Zero Trust moment

Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership

By Matthew Ocko, Zachary Bogue

The hard problem of hardware attacks

By James Hardiman

Deep Tech Opportunities Report 40

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to develop better drugs to treat anxiety

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to overhaul regulation and reimbursement for one-and-done treatments

Deep Tech Opportunities Report

Deep Tech Opportunity: Third-generation gene therapy companies are advancing toward cures for major diseases that can be treated in no other way

Deep Tech Opportunities Report

Deep Tech Opportunity: TechBio companies are using data to rethink how we develop new medical treatments